Intervention Review

Rosiglitazone for type 2 diabetes mellitus

  1. Bernd Richter1,*,
  2. Elizabeth Bandeira-Echtler1,
  3. Karla Bergerhoff1,
  4. Christine Clar2,
  5. Susanne H Ebrahim3

Editorial Group: Cochrane Metabolic and Endocrine Disorders Group

Published Online: 18 JUL 2007

Assessed as up-to-date: 29 APR 2007

DOI: 10.1002/14651858.CD006063.pub2

How to Cite

Richter B, Bandeira-Echtler E, Bergerhoff K, Clar C, Ebrahim SH. Rosiglitazone for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2007, Issue 3. Art. No.: CD006063. DOI: 10.1002/14651858.CD006063.pub2.

Author Information

  1. 1

    Universitaetsklinikum Duesseldorf, Heinrich-Heine University, Department of General Practice, Duesseldorf, Germany

  2. 2

    Cochrane Metabolic and Endocrine Disorders Group, Researcher in Systematic Reviews , Berlin, Germany

  3. 3

    Institute for Quality and Efficiency in Health Care, Cologne, Germany

*Bernd Richter, Department of General Practice, Universitaetsklinikum Duesseldorf, Heinrich-Heine University, PO Box 101007, Duesseldorf, 40001, Germany.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 18 JUL 2007


Options for accessing this content:

  • If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.